EchoStar Corporation Acquires Biotech IT Firm Penn

EchoStar Corporation has acquired Pennant Networks for an undisclosed amount. This corporate acquisition sees EchoStar integrating Pennant Networks' specialized capabilities into its operations.

Pennant Networks provides high-level biotech IT consulting solutions, guiding organizations from molecule to market.

The company offers expert design and implementation of tailored IT solutions, including fractional vCIO and vCISO services.

Pennant's consultants focus on ensuring secure, compliant systems, helping clients navigate regulatory complexities, avoid technical debt, optimize productivity, and accelerate time-to-market within the highly nuanced biotechnology field.

Their services span new IT infrastructure setup, productivity tool investment, cybersecurity bolstering, and managing IT systems and data from divestitures.

Pennant Networks brings deep industry connections, long-term relationships, strong technology partnerships, and proprietary playbooks to its clients.

This expertise ensures that biotech companies have the necessary tools and resources to thrive, acting as a trusted partner for quick, secure, and compliant IT progression.

The acquisition is strategic for EchoStar Corporation, allowing it to expand its service offerings into the specialized and highly regulated biotechnology sector.

By integrating Pennant Networks, EchoStar gains access to a team with profound domain knowledge and a proven track record in delivering critical IT solutions tailored for biotech firms.

The synergy is expected to combine EchoStar's broader resources with Pennant's niche expertise and compliance focus, enhancing the value proposition for clients.

The combined entity is now positioned to offer a more comprehensive and specialized suite of IT consulting and support services to the biotechnology industry, leveraging Pennant's deep understanding of the sector's unique challenges and opportunities.